HighTower Advisors LLC Lowers Position in BlackRock Health Sciences Trust $BME

HighTower Advisors LLC cut its holdings in BlackRock Health Sciences Trust (NYSE:BMEFree Report) by 2.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,985 shares of the company’s stock after selling 544 shares during the quarter. HighTower Advisors LLC’s holdings in BlackRock Health Sciences Trust were worth $1,004,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Ameriprise Financial Inc. lifted its stake in BlackRock Health Sciences Trust by 5.3% in the fourth quarter. Ameriprise Financial Inc. now owns 172,829 shares of the company’s stock worth $6,554,000 after acquiring an additional 8,622 shares during the period. Cornerstone Advisory LLC lifted its stake in BlackRock Health Sciences Trust by 13.3% in the fourth quarter. Cornerstone Advisory LLC now owns 152,301 shares of the company’s stock worth $6,119,000 after acquiring an additional 17,847 shares during the period. LPL Financial LLC lifted its stake in BlackRock Health Sciences Trust by 4.0% in the first quarter. LPL Financial LLC now owns 54,624 shares of the company’s stock worth $2,111,000 after acquiring an additional 2,124 shares during the period. Cambridge Investment Research Advisors Inc. lifted its stake in BlackRock Health Sciences Trust by 14.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 50,654 shares of the company’s stock worth $1,957,000 after acquiring an additional 6,257 shares during the period. Finally, Janney Montgomery Scott LLC lifted its stake in BlackRock Health Sciences Trust by 7.0% in the first quarter. Janney Montgomery Scott LLC now owns 35,074 shares of the company’s stock worth $1,355,000 after acquiring an additional 2,287 shares during the period.

BlackRock Health Sciences Trust Stock Up 0.2%

NYSE:BME opened at $36.60 on Wednesday. BlackRock Health Sciences Trust has a 1-year low of $34.18 and a 1-year high of $42.64. The company has a 50-day moving average of $36.11 and a 200 day moving average of $37.04.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a dividend of $0.2621 per share. This represents a c) annualized dividend and a dividend yield of 8.6%. The ex-dividend date of this dividend is Friday, August 15th.

BlackRock Health Sciences Trust Profile

(Free Report)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Featured Articles

Institutional Ownership by Quarter for BlackRock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.